2016HAL (Le Centre pour la Communication Scientifique Directe)Requires access

Development and comparison of liposomes and nanocapsules as injectable nanocarriers for poorly aqueous soluble drugs

Reatul Karim, C Pallazo, Julie Laloy, Élise Lepeltier, Anne-Sophie Delvigne, Jean‐Michel Dogné, Brigitte Évrard, Catherine Passirani-Malleret, Géraldine Piel

Open publisher page 0 citations

Abstract

About 90% of drugs in development phase have poor aqueous solubility. Liposomes and nanocapsules are promising approaches that enable parenteral administration of these drugs with possibilities of site specific delivery. The objective of the study was to develop different liposomes and lipid nanocapsules entrapping a hydrophobic model molecule (apigenin (AG)), and to characterize and compare them as potential injectable nanocarriers (NCs) for drugs with low aqueous solubility.

About this research paper

What this paper is about

About 90% of drugs in development phase have poor aqueous solubility. Liposomes and nanocapsules are promising approaches that enable parenteral administration of these drugs with possibilities of site specific delivery. The objective of the study was to develop different liposomes and lipid nanocapsules entrapping a hydrophobic model molecule (apigenin (AG)), and to characterize and compare them as potential injectable nanocarriers (NCs) for drugs with low aqueous solubility.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

About 90% of drugs in development phase have poor aqueous solubility. Liposomes and nanocapsules are promising approaches that enable parenteral administration of these drugs with possibilities of site specific delivery. The objective of the study was to develop different liposomes and lipid nanocapsules entrapping a hydrophobic model molecule (apigenin (AG)), and to characterize and compare them as potential injectable nanocarriers (NCs) for drugs with low aqueous solubility.

Key concepts: Nanocarriers, Nanocapsules, Liposome, Aqueous solution, Nanotechnology, Chemistry, Pharmacology, Materials science

Related papers

Back to paper searchBrowse research topicsOriginal source
Development and comparison of liposomes and nanocapsules as injectable nanocarriers for poorly aqueous soluble drugs — Research Paper | ScholarLens